Targeting Mitochondrial Metabolism Shows Promise in Pancreatic Cancer
They say: “This study provides encouraging evidence for a novel, potentially effective combination chemotherapy regimen […] that was safe and well tolerated in patients with metastatic pancreatic cancer.” Read more . . .